Medical articles
IA-controlled oxygen therapy: 85% of the time in target versus 63% in manual setting
The randomized SAVE-O2 AI trial, conducted in 300 patients in four U.S. hospitals, shows that an automated oxygen flow adjustment holds the therapeutic range much better than caregivers.